KRTX Past Earnings image   This KRTX past earnings page last updated 8/10/2022
KRTX Past Earnings
PeriodPast Earnings DateGAAP
Q2 20228/8/2022-2.170
Q1 20225/5/2022-1.950
Q4 20212/24/2022-0.940
Q3 202111/4/2021-1.720
Q2 20218/5/2021-1.170
Q1 20215/6/2021-1.100
Q4 20202/25/2021-0.890
Q3 202011/5/2020-0.710
Q2 20208/5/2020-0.650
Q1 20205/7/2020-0.330
Q4 20193/24/2020-0.320
Q3 201911/7/2019-0.390
Q2 20198/8/2019-146.020
KRTX Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/8/20220.01B
Q1 20225/5/2022NA
Q4 20212/24/20220.04B
Q3 202111/4/2021NA
Q2 20218/5/2021NA
Q1 20215/6/2021NA
Q4 20202/25/2021NA
Q3 202011/5/2020NA
Q2 20208/5/2020NA
Q1 20205/7/2020NA
Q4 20193/24/2020NA
Q3 201911/7/2019NA
Q2 20198/8/2019NA
Quotes delayed 20 minutes

Email EnvelopeFree KRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Karuna Therapeutics (KRTX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

KRYS Past Earnings
KTRA Past Earnings
KTTA Past Earnings
KURA Past Earnings
KYMR Past Earnings
KZR Past Earnings
LAB Past Earnings
LABP Past Earnings
LBPH Past Earnings
LCI Past Earnings

KRTX Past Earnings Q&A

What was the best and worst KRTX past earnings results?
For Karuna Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest KRTX past earnings result in our data set was -0.320/share posted in Q4 2019, while the lowest was in Q2 2019 when KRTX posted -146.020/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when KRTX reported 0.04B in revenue, while the quarter with the lowest revenue in our data set was Q1 2022 at NA of revenue.

  Suggested answer: There are 13 KRTX past earnings results in our data set.

On this page we presented the KRTX past earnings date information for Karuna Therapeutics. Reviewing that KRTX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2019, when KRTX posted gaap of -0.320/share. Meanwhile the lowest KRTX past earnings result was in Q2 2019, when KRTX posted gaap of -146.020/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when KRTX reported 0.04B in revenue, while the smallest revenue quarter was Q1 2022 when KRTX reported NA in revenue.

Any self directed investor doing their due diligence on KRTX or any other given stock can benefit from researching all of the Karuna Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Karuna Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for KRTX. Thanks for visiting, and the next time you need to research KRTX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of IWS, TSRE Insider Buying, Top Ten Hedge Funds Holding HEWW.

 

KRTX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.